“I don’t want to shock anyone, but there may be a need for people to get an additional booster in the fall,” Marks said. They will also discuss options for boosting schedules, which will be guided by what studies show about how long protection from booster doses seems to last. The independent experts will review the emerging data to determine whether continuing to boost with the existing vaccines, or boosting with modified vaccines targeting variants, would provide the best protection against disease. Peter Marks, director of the FDA Center for Biologics Evaluation and Research, in a briefing on March 29.Īs for healthy adults younger than 50, the FDA’s vaccine advisory committee will most likely discuss the available data on April 6 and come up with a more focused plan about COVID-19 boosters. “The FDA believes this option will help to save lives and prevent severe outcomes among the highest risk patients,” said Dr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |